1. Home
  2. SIBN vs VALN Comparison

SIBN vs VALN Comparison

Compare SIBN & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SI-BONE Inc.

SIBN

SI-BONE Inc.

N/A

Current Price

$18.54

Market Cap

778.8M

Sector

Health Care

ML Signal

N/A

Logo Valneva SE

VALN

Valneva SE

N/A

Current Price

$6.67

Market Cap

653.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SIBN
VALN
Founded
2008
2012
Country
United States
France
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
778.8M
653.3M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
SIBN
VALN
Price
$18.54
$6.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
2
Target Price
$23.88
$15.50
AVG Volume (30 Days)
505.2K
27.6K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
41.33
N/A
EPS
N/A
N/A
Revenue
$67,301,000.00
N/A
Revenue This Year
$16.95
N/A
Revenue Next Year
$14.93
$93.87
P/E Ratio
N/A
N/A
Revenue Growth
21.53
N/A
52 Week Low
$11.48
$4.75
52 Week High
$21.89
$12.23

Technical Indicators

Market Signals
Indicator
SIBN
VALN
Relative Strength Index (RSI) 51.17 55.11
Support Level $18.34 $6.29
Resistance Level $19.35 $6.69
Average True Range (ATR) 0.64 0.20
MACD -0.07 -0.07
Stochastic Oscillator 42.74 26.92

Price Performance

Historical Comparison
SIBN
VALN

About SIBN SI-BONE Inc.

SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: